PRACTICE Guidelines REGISTRATION PLATFORM

News MORE

2021.0902

Clinical Epidemiology in China series. Paper 2: Promoting GRADE at the national level: the experience from China

Recently, a series of articles from Chinese scholars have been published in the Journal of Clinical Epidemiology.

2021.0902

Clinical Epidemiology in China series. Paper 1: Evidence-based medicine in China: an oral history study

Recently, a series of articles from Chinese scholars have been published in the Journal of Clinical Epidemiology.

2021.0630

“Guideline Assessment Project II: statistical calibration informed the development of an AGREE II extension for surgical guidelines” published online

On 22 June 2021, the article Guideline Assessment Project II: statistical calibration informed the development of an AGREE II extension for surgical guidelines by Sofia Tsokani et al. was published online on the official website of the Surgical Endoscopy.

2022.0123

Clinical practice guideline for diagnosis and treatment of de novo stage lV breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2022 IPGRP-2022CN048

To standardize the surgical diagnosis and treatment of de novo stage IV breast cancer, the Chinese Society of Breast Surgery (CSBrS) evaluated the relevant evidences using the Grading of Recommendations Assessment, Development, and Evaluation system and combined the accessibility under China's national conditions and developed the Clinical practice guidelines for diagnosis and treatment of de novo stage lV breast cancer:Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 with the aim of providing guidance to the clinical practices of breast surgeons in China.

2022.0123

Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer 2022.V1（CSBrS-Guideline-21) IPGRP-2022CN046

In order to improve the clinical diagnosis and treatment of inflammatory breast cancer (IBC), the Chinese Medical Association Surgery Branch organized experts to put forward key clinical issues related to the clinical practice of IBC through literature research and discussion. Development and Evaluation) system to evaluate relevant evidence, and combined with clinical accessibility in China, the Chinese Medical Association IBC clinical practice guidelines are formulated, aiming to provide reference for Chinese breast cancer and other professional physicians.

2022.0123

Clinical practice guideline for neoadjuvant therapy in early-stage breast cancer (CSBrS-Guideline-23) IPGRP-2022CN044

There has been widespread consensus that neoadjuvant therapy can bring clinical benefits in early breast cancer. The purpose and significance of neoadjuvant therapy have also been enriched, including more indications, treatment options and therapeutic evaluation. The Chinese Society of Breast Surgery organized related experts to discuss the neoadjuvant therapy of breast cancer, and evaluated the relevant evidence with reference to the GRADE system, aiming to provide reference for China's breast surgeons.

Guidelines Interpretation

Database